iwNHL 2018 Session III

Viral driven Lymphoma

Speaking in session III of iwNHL 2018,  Ruth Jarrett, MD, PhD, Mark Roschewski, MD, Richard Little, MD, and Catherine Bollard, MD, discuss risk factors, clinical aspects and treatment of virus-driven lymphomas.

Presentations
Risk Factors for EBV-associated Lymphomas
Ruth Jarret
University of Glasgow, Glasgow, Scotland
22 September, 2018

Ruth Jarret, MD, PhD, from University of Glasgow, Glasgow, Scotland speaks on the risk factors for EBV-associated lymphomas.

PTLD and LYG
Mark Roschewski
National Cancer Institute, Bethesda, MD
22 September, 2018

Mark Roschewski, MD, from National Cancer Institute, Bethesda, MD, talks about EBV-associated lymphoproliferative disorders.

HIV-associated Lymphomas
Richard Little
National Cancer Institute, Bethesda, MD
22 September, 2018

Richard Little, MD, from National Cancer Institute, Bethesda, MD, discusses the clinical aspects and management of AIDS-related lymphoma.

Cell Therapies for Viral Driven Lymphomas (HIV, EBV)
Catherine Bollard
Children’s National Medical Center, Washington, DC
22 September, 2018

Catherine Bollard, MD, Children’s National Medical Center, Washington, DC, gives a talk on the use of T-cells for treating lymphomas driven by viruses.